These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 987514)

  • 21. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
    Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
    J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On the correlation of luteinizing hormone-releasing hormone, luteinizing hormone, follicle-stimulating hormone, and prolactin levels in plasma of women with normal menstrual cycles.
    Aksel S
    Am J Obstet Gynecol; 1981 Oct; 141(4):362-7. PubMed ID: 6792924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ability of luteinizing hormone (LH) to acutely increase serum progesterone levels during the secretory phase of the rhesus menstrual cycle.
    Macdonald GJ; Greep RO
    Fertil Steril; 1972 Jul; 23(7):466-70. PubMed ID: 4624776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary gonadotrophin secretion during the first weeks of pregnancy.
    Jeppsson S; Rannevik G; Thorell JI
    Acta Endocrinol (Copenh); 1977 May; 85(1):177-88. PubMed ID: 324219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian follicular and luteal physiology.
    Channing CP; Schaerf FW; Anderson LD; Tsafriri A
    Int Rev Physiol; 1980; 22():117-201. PubMed ID: 6248477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between symptom severity and hormone changes in women with premenstrual syndrome.
    Hammarbäck S; Damber JE; Bäckström T
    J Clin Endocrinol Metab; 1989 Jan; 68(1):125-30. PubMed ID: 2491857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of RU 486 administered during the early luteal phase on bleeding pattern, hormonal parameters and endometrium.
    Swahn ML; Bygdeman M; Cekan S; Xing S; Masironi B; Johannisson E
    Hum Reprod; 1990 May; 5(4):402-8. PubMed ID: 2113927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental studies on the endocrine regulations during the periovulatory phase of the human menstrual cycle. The effects of exogenous 17 -oestradiol and progesterone on the release of pituitary luteinizing and follicle stimulating hormones.
    Leyendecker G; Wardlaw S; Nocke W
    Acta Endocrinol (Copenh); 1972 Sep; 71(1):160-78. PubMed ID: 4678011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luteinizing hormone-releasing hormone (LH-RH) as a diagnostic and research tool in gynecologic endocrinology.
    Taymor ML; Thompson IE; Berger MJ; Patton W
    Am J Obstet Gynecol; 1974 Nov; 120(6):721-32. PubMed ID: 4611213
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mifepristone (RU486) on the pituitary response to gonadotrophin releasing hormone in women.
    Kazem R; Messinis LE; Fowler P; Groome NP; Knight PG; Templeton AA
    Hum Reprod; 1996 Dec; 11(12):2585-90. PubMed ID: 9021355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum follicle-stimulating and luteinizing hormone and progesterone in single and multiple gestations following induction of ovulation.
    Fogel M; Rubin BL; Ossowski R
    Am J Obstet Gynecol; 1972 Mar; 112(5):629-39. PubMed ID: 5059593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of serum LH and FSH in response to 4-hour infusions of luteinizing hormone releasing hormone in normal women during menstrual cycle, on oral contraceptives, and in postmenopausal state.
    de Kretser DM; Burger HG; Dumpys R
    J Clin Endocrinol Metab; 1978 Feb; 46(2):227-35. PubMed ID: 374423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma gonadotropin and sex steroid hormone levels during early, midfollicular, and midluteal phases of women with luteal phase defects.
    Cook CL; Rao CV; Yussman MA
    Fertil Steril; 1983 Jul; 40(1):45-8. PubMed ID: 6407879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of sex steroids on pituitary responsiveness to gonadotropin releasing hormone.
    Eshkol A; Lunenfeld B; Insler V
    J Steroid Biochem; 1975 Jun; 6(6):1061-6. PubMed ID: 1100906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age related changes in follicle stimulating hormone, luteinizing hormone, oestradiol and immunoreactive inhibin in women of reproductive age.
    MacNaughton J; Banah M; McCloud P; Hee J; Burger H
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):339-45. PubMed ID: 1424166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interruption of endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential.
    Greene KE; Kettel LM; Yen SS
    Fertil Steril; 1992 Aug; 58(2):338-43. PubMed ID: 1633899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.